TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›SNPS

SNPS

SYNOPSYS INC

Next earnings Sep 7, 2026 · consensus $3.74 EPS, $2.49B rev

Last earnings -1.6% on 2026-05-27

Hold
$437.16
▼ -2.26%
$437.16▼ -13.03%
over 1Y
L $380.47H $645.35
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-2.3%
1W-3.9%
1M-14.0%
3M+10.4%
YTD-9.0%
1Y-13.0%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
C
Valuation
Overvalued
Filings
Watch
Hold
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 31 analysts
Buy

Best-in-class EDA franchise, but 57x earnings collide with Ansys-diluted profits, China weakness and a guided-muted FY2026.

Revenue (FY2025) $7.05B · FY2025

The read

Middling fundamentals and a rich price (~85% above fair value) leave little margin of safety — a wait-and-see.

Synopsys is a structurally advantaged business — an EDA/IP duopoly franchise with 77.0% gross margins, ~$7.05B revenue growing 15.1%, and a license model that recognizes revenue over two-to-three-year arrangements, smoothing demand shocks (MD&A: 'decreases as well as increases in customer spending do not immediately affect our revenue in a significant way'). Revenue has compounded every year from $4.20B (FY2021) to $7.05B (FY2025), and R&D spend rose 19.1% to $2.48B, protecting the moat. This is a quality compounder, not a broken story.

But the FY2025 print is messier than the top line. Operating income fell 32.5% to $915M and operating margin compressed to just 13.0%, because the closed Ansys Merger added $457.8M of intangible amortization and $432.1M of acquired headcount cost while contributing only $756.6M of revenue. The headline -41.1% net income / -44.6% EPS drop is partly optical — FY2024 net income included an $821.7M discontinued-ops gain from the Software Integrity divestiture, and continuing-ops net income was actually $1,336.1M vs $1,441.7M (≈-7%). Still, the deal reshaped the balance sheet: long-term debt went from near-zero to $13.5B, share count rose 23.8% to 191M (dilution), assets +268.9%, and ROE collapsed to 4.7% on the enlarged equity base. Leverage is digestible (liabilities/equity 0.70x), but the days of a debt-free, high-ROE Synopsys are over.

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 11:09 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$4.20B$4.62B$5.32B$6.13B$7.05B
Gross profit$3.34B$3.72B$4.29B$4.88B$5.43B
Operating income$735M$1.15B$1.27B$1.36B$915M
Net income$758M$985M$1.23B$2.26B$1.33B
Diluted EPS$4.81$6.29$7.92$14.51$8.04
Net margin18.0%21.3%23.1%36.9%18.9%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$94.3B
EV / EBITDA59.9
EV / Sales13.4
EV / FCF69.9
P / FCF62.0
PEG (trailing)—
Earnings yield1.6%
FCF yield1.6%

Quality & risk

ROIC (est.)1.7%
Free cash flow$1.35B
Total debt$13.5B
Net cash-$10.6B
Altman Z-Score3.09 safe
Piotroski F-Score3/9

Capital returns

Buyback yield0.0%
Dividend yield (est.)—
Shareholder yield0.0%
Shares Δ YoY+23.8%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Officer / director change2026-05-27
  2. 8-K Earnings results2026-05-27
  3. 10-Q Quarterly report2026-05-27
  4. 8-K Officer / director change2026-04-20
  5. 8-K Other event2026-03-02
  6. 8-K Earnings results2026-02-25
  7. 10-Q Quarterly report2026-02-25
  8. 8-K Officer / director change2026-02-19
  9. DEF 14A Proxy statement2026-02-19

Recent filings

all on EDGAR ↗
4Period ending 2026-06-152026-06-16open ↗4Period ending 2026-06-152026-06-16open ↗4Period ending 2026-06-152026-06-16open ↗4Period ending 2026-06-152026-06-16open ↗4Period ending 2026-06-152026-06-16open ↗4Period ending 2026-06-152026-06-16open ↗144Filing2026-06-15open ↗4Period ending 2026-06-122026-06-15open ↗144Filing2026-06-12open ↗4Period ending 2026-06-012026-06-02open ↗4Period ending 2026-06-012026-06-02open ↗3Period ending 2026-06-012026-06-02open ↗

Quality score

C
ValueGrowthProfitHealthMom.
ValueF
GrowthD
ProfitabilityB
Financial healthA-
MomentumF
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
  • ✗P/E below 25

Fair value est.

$64.58

Overvalued -85% vs price

cheapfair valueexpensive

Modified Graham: EPS $8.04 × (8.5 + 1.5 × 0.0% growth) × 0.95 quality = 8.0× multiple. An estimate, not a price target.

380.4752-week645.35
Revenue
$7.05B
+15.1% YoY
Net margin
18.9%
ROE
4.7%
P/E
54.4

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$7.05B+15.1%
Net income$1.33B-41.1%
Gross profit$5.43B+11.2%
Operating income$915M-32.5%
Diluted EPS$8.04-44.6%
Cash & equivalents$2.89B-25.9%
Total assets$48.2B+268.9%
Total liabilities$19.9B+391.3%
Stockholders' equity$28.3B+215.1%
Gross: 77.0%Op.: 13.0%L/E: 0.70x

Frequently asked

Is SYNOPSYS INC (SNPS) a buy?
SNPS currently carries a Hold rating with 4/5 conviction, derived from its latest SEC filings. Best-in-class EDA franchise, but 57x earnings collide with Ansys-diluted profits, China weakness and a guided-muted FY2026.
What is SNPS's fair value?
A Modified-Graham model based on SNPS's SEC fundamentals estimates a fair value of about $64.58. It is an estimate from reported earnings, not a price target.
Is SNPS overvalued or undervalued?
Against a Modified-Graham fair-value estimate, SNPS currently appears overvalued relative to its SEC-grounded earnings power.
What is SYNOPSYS INC's quality score?
SNPS scores 56.141829341066206/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000883241, latest 10-Q filed 2026-05-27) · EODHD · Proprietary analysis · as of 6/21/2026, 3:09:00 PM.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 2 sales

2026-06-15
Ellow Michael
Chief Revenue Officer
Exercise4.05K
2026-06-15
Ellow Michael
Chief Revenue Officer
Tax2.01K @ $454.38$912K
2026-06-15
Ellow Michael
Chief Revenue Officer
Exercise1.08K
2026-06-15
Ellow Michael
Chief Revenue Officer
Tax536.00 @ $454.38$244K
2026-06-15
LEE JANET
GC & Corporate Secretary
Exercise540.00
2026-06-15
LEE JANET
GC & Corporate Secretary
Tax235.00 @ $454.38$107K
2026-06-15
Kankanwadi Sudhindra
Deputy CFO & CAO
Exercise720.00
2026-06-15
Kankanwadi Sudhindra
Deputy CFO & CAO
Tax249.00 @ $454.38$113K
2026-06-15
Glaser Shelagh
CFO
Exercise1.26K
2026-06-15
Glaser Shelagh
CFO
Tax436.00 @ $454.38$198K
2026-06-15
Ghazi Sassine
PRESIDENT AND CEO
Exercise14.6K @ $135.88$1.98M
2026-06-15
Ghazi Sassine
PRESIDENT AND CEO
Sell14.6K @ $458.96$6.70M

Earnings history

beat/miss · move
2026-05-27Beat +3.9% est▼ -1.62%8-K ↗
2026-02-25Beat +2.4% est▲ +1.92%8-K ↗
2025-12-10Miss -10.9% est▲ +2.14%8-K ↗
2025-09-09—▼ -0.77%8-K ↗
2025-05-28—▼ -9.64%8-K ↗
2025-02-26—▲ +2.73%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

1 buy · 1 member · last 180d

+$8.00K net boughtlast trade 186d ago
$8.00K bought$0.00 sold
2026-01-15Dan NewhouseBuy$1.00K–$15.0KPTR ↗
2025-12-15Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2025-11-18Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2025-10-22Lisa McClainSell$1.00K–$15.0KPTR ↗
2025-09-12Valerie HoyleBuy$1.00K–$15.0KPTR ↗
2025-09-12Lisa McClainBuy$1.00K–$15.0KPTR ↗
2025-08-14Julie JohnsonExchange$1.00K–$15.0KPTR ↗
2025-08-13Lisa McClainBuy$1.00K–$15.0KPTR ↗
2025-08-13Lisa McClainSell$1.00K–$15.0KPTR ↗
2025-06-22Jefferson ShreveSell$50.0K–$100KPTR ↗
2025-05-08Jefferson ShreveBuy$50.0K–$100KPTR ↗
2025-04-28Rob BresnahanSell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Recent news

market news →
Synopsys, Inc. (SNPS) is Attracting Investor Attention: Here is What You Should KnowBullish
finance.yahoo.com· 2026-07-02
Data Shows Why This Software ETF is Poised to RallyBullish
finance.yahoo.com· 2026-07-01
Price Prediction: Synopsys’ Chip-Design Moat and The Path to 24% UpsideBullish
finance.yahoo.com· 2026-06-29
Piper Sandler Upgrades “Overweight” from Neutral on Synopsys, Inc. (SNPS)Bullish
finance.yahoo.com· 2026-06-28
Why Is Synopsys (SNPS) Down 5.3% Since Last Earnings Report?Bullish
finance.yahoo.com· 2026-06-26
Synopsys (SNPS) Stock Gets Fair Value Trim As Analysts Weigh Ansys And IP RecoveryBullish
finance.yahoo.com· 2026-06-24

Vs Information Technology peers

compare →

163 tracked peers · median

TENK Score56 vs 62
Revenue growth15.1% vs 15.5%
Net margin18.9% vs 10.2%
Return on equity4.7% vs 9.1%
P/E54.4 vs 44.7
Peers
QLYSGENCRUSACIWFFIVZMFSLRAPH

News sentiment

EODHD · 44d
Bullish
+0.16
vs typical · 142 articles

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.